140
Participants
Start Date
March 21, 2024
Primary Completion Date
September 30, 2026
Study Completion Date
December 30, 2026
Bioactive Glass
Bonalive Granules and Bonalive Putty will be used (according to their IFU and CE certification) to fill the bone void after the debridment of infected tissue as they have osteoconductive and osteostimulative properties that allow bone rigeneration. Moreover, Bonalive Granules also present some bacteria growth inhibiting properties to combact bone infection propoer of Ostemyelitis.
Standard of Care
The investigators are left free to proceed according to the normal standar procedure they normally use. The procedures can vary according to investigator judgment also depending on the state of Osteomylitis.
NOT_YET_RECRUITING
AOU Pisana - Ospedale di Cisanello, Pisa
RECRUITING
ASST Ovest Milanese - Ospedale di Abbiategrasso, Abbiategrasso
NOT_YET_RECRUITING
ASUGI Azienda Sanitaria Universitaria Giuliano Isontina - Ospedale Monfalcone, Monfalcone
NOT_YET_RECRUITING
Casa di Cura Abano Terme - POLICLINICO ABANO TERME, Abano Terme
NOT_YET_RECRUITING
AUSL Romagna - Ospedale Morgagni Pierantoni, Forlì
NOT_YET_RECRUITING
USL Sud Est Toscana - Ospedale San Donato, Arezzo
NOT_YET_RECRUITING
Azienda USL Toscana Nord Ovest - Ospedale Campo di Marte, Lucca
Collaborators (1)
Hippocrates Research
OTHER
Bonalive Biomaterials Ltd
INDUSTRY
ASST Ovest Milanese
OTHER